Key facts
- Notable investors include Hexa, Won & Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Enolink
- ·The full record, as it builds
Funding rounds
No funding rounds for Enolink are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enolink
Developer of computer software designed to predict disease and drug efficacy based on real-world data (RWD) throughout the life cycle. The company offers to cover the categories of computer software using artificial intelligence for providing, analyzing, and generating reports, enabling users to control and manage data and information related to healthcare services and patient medical information.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2018
- Employees
- 17
- Website
- enolink.com/
- Ownership
- Privately Held (backing)
Enolink doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enolink shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enolink in its N-PORT filings yet. We sweep new filings monthly.